VivoSeq
Other

General Anesthesia

0

Pipeline Programs

18

Active Trials

2

Companies Involved

General Anesthesia is an early-stage landscape with 0 programs across 2 companies. The most active players are Haisco Pharmaceutical Group Co., Ltd., Merck & Co..

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

92/100

Attrition Rate

5/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

133

clinical trials

Completed82 · 62%
Unknown status26 · 20%
Recruiting12 · 9%
Terminated5 · 4%
Not yet recruiting5 · 4%
Withdrawn2 · 2%
Other1 · 1%

Trial Activity

133 trials

Page 1 of 9

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)